Abstract:Chlamydia is responsible for millions of new infections annually, and current efforts focus on understanding cellular immunity for targeted vaccine development. The Chlamydia-specific CD4 T cell response is characterized by the production of IFNγ, and polyfunctional Th1 responses are associated with enhanced protection. A major limitation in studying these responses is the paucity of tools available for detection, quantification, and characterization of polyfunctional, antigen-specific T cells. We addressed th… Show more
“…4). While this has previously been shown indirectly (8,14,15,22), our use of IFN-␥ Ϫ/Ϫ NR1 T cells confirms the importance of IFN-␥ production during C. trachomatis infection. Interestingly, IFN-␥R Ϫ/Ϫ NR1 T cells were still able to protect mice, suggesting that their ability to produce IFN-␥ was enough to help clear infection.…”
Section: Discussionsupporting
confidence: 84%
“…Those studies showed that antigen-specific CD8 ϩ T cells do localize in sections of the genital tract containing LCMV, correlating with our findings with C. trachomatis. Given this, it is possible that transgenic CD8 ϩ T cells specific for C. trachomatis protein CrpA (7) or transgenic CD4 ϩ T cells corresponding to C. muridarum (8) would similarly be able to home to the specific sites within the genital tract that contain bacteria. Future work will address whether or not this is an NR1 or transcervical inoculation-specific phenomenon within the context of Chlamydia infection.…”
Section: Discussionmentioning
confidence: 99%
“…address questions regarding antigen-specific T cells in naive mice (6)(7)(8). We have previously established one such transgenic mouse, denoted the NR1 mouse, in which CD4 ϩ T cells are specific for the C. trachomatis protein Cta1 (6).…”
mentioning
confidence: 99%
“…Indeed, it has been shown that IFN-␥ is essential for host clearance of Chlamydia (14)(15)(16)(17)(18)(19). It is thought that antigen-specific CD4 ϩ T cells can help control infection through their production of IFN-␥, as endogenous C. trachomatis-specific CD4 ϩ T cells (14) and transgenic CD4 ϩ T cells corresponding to both C. trachomatis and the mouse-adapted pathogen C. muridarum (8,14,15) have all been shown to produce IFN-␥. However, it is unknown if antigen-specific T cell production or sensing of IFN-␥ is absolutely required for homing to the genital tract or for clearing infection.…”
While there is no effective vaccine against Chlamydia trachomatis infection, previous work has demonstrated the importance of C. trachomatis-specific CD4+ T cells (NR1 T cells) in pathogen clearance. Specifically, NR1 T cells have been shown to be protective in mice, and this protection depends on the host’s ability to sense the cytokine gamma interferon (IFN-γ). However, it is unclear what role NR1 production or sensing of IFN-γ plays in T cell homing to the genital tract or T cell-mediated protection against C. trachomatis. Using two-photon microscopy and flow cytometry, we found that naive wild-type (WT), IFN-γ−/−, and IFN-γR−/− NR1 T cells specifically home to sections in the genital tract that contain C. trachomatis. We also determined that protection against infection requires production of IFN-γ from either NR1 T cells or endogenous cells, further highlighting the importance of IFN-γ in clearing C. trachomatis infection.
IMPORTANCE Chlamydia trachomatis is an important mucosal pathogen that is the leading cause of sexually transmitted bacterial infections in the United States. Despite this, there is no vaccine currently available. In order to develop such a vaccine, it is necessary to understand the components of the immune response that can lead to protection against this pathogen. It is well known that antigen-specific CD4+ T cells are critical for Chlamydia clearance, but the contexts in which they are protective or not protective are unknown. Here, we aimed to characterize the importance of gamma interferon production and sensing by T cells and the effects on the immune response to C. trachomatis. Our work here helps to define the contexts in which antigen-specific T cells can be protective, which is critical to our ability to design an effective and protective vaccine against C. trachomatis.
“…4). While this has previously been shown indirectly (8,14,15,22), our use of IFN-␥ Ϫ/Ϫ NR1 T cells confirms the importance of IFN-␥ production during C. trachomatis infection. Interestingly, IFN-␥R Ϫ/Ϫ NR1 T cells were still able to protect mice, suggesting that their ability to produce IFN-␥ was enough to help clear infection.…”
Section: Discussionsupporting
confidence: 84%
“…Those studies showed that antigen-specific CD8 ϩ T cells do localize in sections of the genital tract containing LCMV, correlating with our findings with C. trachomatis. Given this, it is possible that transgenic CD8 ϩ T cells specific for C. trachomatis protein CrpA (7) or transgenic CD4 ϩ T cells corresponding to C. muridarum (8) would similarly be able to home to the specific sites within the genital tract that contain bacteria. Future work will address whether or not this is an NR1 or transcervical inoculation-specific phenomenon within the context of Chlamydia infection.…”
Section: Discussionmentioning
confidence: 99%
“…address questions regarding antigen-specific T cells in naive mice (6)(7)(8). We have previously established one such transgenic mouse, denoted the NR1 mouse, in which CD4 ϩ T cells are specific for the C. trachomatis protein Cta1 (6).…”
mentioning
confidence: 99%
“…Indeed, it has been shown that IFN-␥ is essential for host clearance of Chlamydia (14)(15)(16)(17)(18)(19). It is thought that antigen-specific CD4 ϩ T cells can help control infection through their production of IFN-␥, as endogenous C. trachomatis-specific CD4 ϩ T cells (14) and transgenic CD4 ϩ T cells corresponding to both C. trachomatis and the mouse-adapted pathogen C. muridarum (8,14,15) have all been shown to produce IFN-␥. However, it is unknown if antigen-specific T cell production or sensing of IFN-␥ is absolutely required for homing to the genital tract or for clearing infection.…”
While there is no effective vaccine against Chlamydia trachomatis infection, previous work has demonstrated the importance of C. trachomatis-specific CD4+ T cells (NR1 T cells) in pathogen clearance. Specifically, NR1 T cells have been shown to be protective in mice, and this protection depends on the host’s ability to sense the cytokine gamma interferon (IFN-γ). However, it is unclear what role NR1 production or sensing of IFN-γ plays in T cell homing to the genital tract or T cell-mediated protection against C. trachomatis. Using two-photon microscopy and flow cytometry, we found that naive wild-type (WT), IFN-γ−/−, and IFN-γR−/− NR1 T cells specifically home to sections in the genital tract that contain C. trachomatis. We also determined that protection against infection requires production of IFN-γ from either NR1 T cells or endogenous cells, further highlighting the importance of IFN-γ in clearing C. trachomatis infection.
IMPORTANCE Chlamydia trachomatis is an important mucosal pathogen that is the leading cause of sexually transmitted bacterial infections in the United States. Despite this, there is no vaccine currently available. In order to develop such a vaccine, it is necessary to understand the components of the immune response that can lead to protection against this pathogen. It is well known that antigen-specific CD4+ T cells are critical for Chlamydia clearance, but the contexts in which they are protective or not protective are unknown. Here, we aimed to characterize the importance of gamma interferon production and sensing by T cells and the effects on the immune response to C. trachomatis. Our work here helps to define the contexts in which antigen-specific T cells can be protective, which is critical to our ability to design an effective and protective vaccine against C. trachomatis.
“…This indicates that establishment of resident T cells from T cells originating from circulation may not be strictly dependent on neither α4 or CD103, but does involve CD69 in agreement with previous studies on CD4 Trm cells in various tissues 46 including the genital tract. 47 Interestingly, our data showed that inhibiting lymphocyte egress from the lymph nodes, including the infectiondraining lymph nodes, resulting in a strong decline in T cell numbers in blood, did not reduce the expansion of T cells in the GT or compromize the protection. This showed that in the first phase of the infection, the Trm cells were sufficient to induce a protective immune response ( Fig.…”
The optimal protective immunity against Chlamydia trachomatis (C.t.) is still not fully resolved. One of the unresolved issues concerns the importance of resident immunity, since a recent study showed that optimal protection against a transcervical (TC) infection required genital tissue-resident memory T cells. An important question in the Chlamydia field is therefore if a parenteral vaccine strategy, inducing only circulating immunity primed at a nonmucosal site, should be pursued by Chlamydia vaccine developers. To address this question we studied the protective efficacy of a parenteral Chlamydia vaccine, formulated in the Th1/ Th17 T cell-inducing adjuvant CAF01. We found that a parenteral vaccination induced significant protection against a TC infection and against development of chronic pathology. Protection correlated with rapid recruitment of Th1/Th17 T cells to the genital tract (GT), which efficiently prevented infection-driven generation of low quality Th1 or Th17 T cells, and instead maintained a pool of high quality multifunctional Th1/Th17 T cells in the GT throughout the infection. After clearance of the infection, a pool of these cells settled in the GT as tissue-resident Th1 and Th17 cells expressing CD69 but not CD103, CD49d, or CCR7, where they responded rapidly to a reinfection. These results show that a nonmucosal parenteral strategy inducing Th1 and Th17 T cells mediates protection against both infection with C.t. as well as development of chronic pathology, and lead to post-challenge protective tissue-resident memory immunity in the genital tract.npj Vaccines (2020) 5:7 ; https://doi.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.